Cito Capital Group, LLC Abbott Laboratories Transaction History

Cito Capital Group, LLC

$268 Million
Q3 2024

A detailed history of Cito Capital Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cito Capital Group, LLC holds 16,200 shares of ABT stock, worth $1.85 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

16,200

Previous 18,950 14.51%

Holding current value

$1.85 Million

Previous $1.97 Million 6.2%

% of portfolio

0.69%

Previous 0.76%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $275,192 - $324,857	-2,750 Reduced 14.51%	16,200 $1.85 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $85,620 - $95,574	850 Added 4.7%	18,950 $1.97 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $18,038 - $22,080	200 Added 1.12%	18,100 $1.99 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $38,212 - $45,848	400 Added 2.29%	17,900 $1.73 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $193,520 - $224,060	-2,000 Reduced 10.26%	17,500 $1.69 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $228,040 - $278,080	-2,000 Reduced 9.3%	19,500 $2.31 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $699,960 - $774,360	-6,000 Reduced 21.82%	21,500 $2.54 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $36,447 - $46,648	476 Added 1.76%	27,500 $2.51 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $32,917 - $48,134	524 Added 1.98%	27,024 $2.13 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $30,405 - $36,680	500 Added 1.92%	26,500 $1.78 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.25 Million - $1.39 Million	26,000	26,000 $0

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cito Capital Group, LLC with notifications on news.

Account

Cito Capital Group, LLC Abbott Laboratories Transaction History